Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Using a custom antigen prediction pipeline, we identified potential tumor rejection antigens with important implications for the development of immunotherapy for medulloblastoma.
Authors
- Vrunda Trivedi (ORCID: https://orcid.org/0000-0001-9781-4761)
- Kate M. Candelario (ORCID: https://orcid.org/0000-0003-2290-2657)
- Oleg Yegorov (ORCID: https://orcid.org/0000-0001-9654-638X)
- Kyle Dyson (ORCID: https://orcid.org/0000-0002-7972-3249)
- Tongjun Gu (ORCID: https://orcid.org/0000-0002-8379-0962)
- Duane A. Mitchell (ORCID: https://orcid.org/0000-0001-6049-213X)
- Changlin Yang (ORCID: https://orcid.org/0000-0002-7315-9165)
Institutions
- University of Florida (US)
- Pediatric Brain Tumor Foundation (US)
Publication Details
- Journal
- Genome Medicine
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s13073-024-01363-y
- Citations
- 4
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- V Foundation for Cancer Research
- University of Florida
- National Institutes of Health
- Clinical and Translational Science Institute, University of Florida